The use of Aspirin in the Preeclampsia Prevention.

Authors

  • Pedro Rodríguez Domínguez POLICLÍNICO DOCENTE DE MILANÉS. MATANZAS.
  • Armando Báez Villa POLICLÍNICO DOCENTE DE MILANÉS. MATANZAS.
  • Juana Elena Domínguez Rodríguez POLICLÍNICO DOCENTE DE MILANÉS. MATANZAS.

Keywords:

PREECLAMPSIA, ASPIRINA, EMBARAZO, HUMANO-ADULTO

Abstract

Beginning January 1/1996 a prospective study was performed in pregnant women who gave birth until April 30 th /1999, enrolled family physician offices, from basic working teams#1 and 2 at Milanés Polyclinic and in whom risks of suffering from eclampsia were deleted. Sixty mg of Aspirin daily was given to pregnant women in basic working team #2 did not take aspirin and conformed the control or untreated group. A series of variables were compiled and studied, arriving to the conclusion that this drug showed are incidence reduction in women at preeclampsia risk, process severity was lower, there were no maternal nor fetal repercussion derived from etc,. usage and retarded intra-uterine growth plus low-weight at birth frequencies were minor.

Downloads

Download data is not yet available.

Downloads

How to Cite

1.
Rodríguez Domínguez P, Báez Villa A, Domínguez Rodríguez JE. The use of Aspirin in the Preeclampsia Prevention. Rev Méd Electrón [Internet]. 2014 Feb. 12 [cited 2025 Jan. 22];24(4):207-11. Available from: https://revmedicaelectronica.sld.cu/index.php/rme/article/view/56

Issue

Vol. 24 No. 4 (2002)

Section

Research article

License

All content published in this journal is Open Access, distributed under the terms of the CC BY-NC 4.0 License.

It allows:

 - Copy and redistribute published material in any medium or format.

 - Adapt the content.

 This will be done under the following terms:

 - Attribute the authors' credits and indicate whether changes were made, in which case it must be in a reasonable way.

 - Non-commercial use.

 - Recognize the journal where it is published.

 The copyrights of each article are maintained, without restrictions.